- 1
- 2
- 3
CDMO Solutions Help Today's Biopharma Executives Mitigate Risk When Time Is Of The Essence
- 1
- 2
- 3
Navigating The Road To Gene Therapy Commercialization
ABOUT MILLIPORESIGMA
The life science business of Merck KGaA, Darmstadt, Germany brings together the world-class products and services, innovative capabilities and exceptional talent of EMD Millipore and Sigma-Aldrich to create a global leader in the life science industry.
At MilliporeSigma, our mission is to help our customers improve human health and life worldwide. This commitment means providing leading life science products and services in ways that also help improve the communities and environment in which we all live.
We re-imagine a future in which:
- Access to health and clean water is available to everyone around the world;
- Life science products not only advance human health, but also help restore and preserve our world; and
- Companies work in harmony with their communities to improve human lives.
We aren’t just re-imagining this future. We are working towards it every day. We invite you to learn more about our leadership commitment and our approach to corporate responsibility, as well as our goals and accomplishments for future-forward products, streamlined operations, and inspired people within and outside of our company.
VIDEOS
BROCHURES
- Ensuring Success With Manufacturing Risk Assessment
- API Stability Combined With Rapid Disintegration
- Stabilizer Brochure
- Digital Data: Your Roadmap To Supply Chain Efficiency
- CDMO Services: Customized mRNA-LNP Solutions
- A First-Of-Its-Kind Advanced Qualification Dossier
- Mobius® ADC Reactor
- A Complete Set Of Rapid Methods For Adventitious Agent Detection
- Viral Clearance Studies To Meet Your Timelines
- Viral Vector CTDMO Services
- Mammalian Biologics CDMO Services To Bring Your Program To The Next Stage
- Accelerating Adenovirus-Based Cell And Gene Therapy Manufacturing
- A Platform For Lentivirus-Based Cell And Gene Therapy Manufacturing
- Large-Scale API Production Services
- Highly Potent And Complex API Contract Manufacturing
- Simplify Your Linker-Payload Synthesis
- An NGS-Based Platform To Streamline Your Genetic Stability Testing
- ADC And Bioconjugation Center Of Excellence
- Comprehensive ADC And Bioconjugation Services For Targeted Therapies
- CTDMO Services To Fast-Track The Advancement Of mRNA-Based Drugs
- Granulated Materials
- Expert Partnership Contract Testing Services
- Accelerated mAb Development Program
- Analytical Development And Characterization For mRNA
- Remote Control And Automation Software Optimized For Bioprocess
- Roadmap To Success: Viral Clearance Services
- Next Generation Sequencing For Sequence Identity Confirmation And Variant Detection
- Reveal Your Biologic's Attributes Earlier And Faster With Expert Guidance
- Closed Processing Cell Bank Manufacturing Services
- Next Generation Sequencing For Biologic Production And Safety
- BioReliance® Cell Banking And Storage
- Viral Vector Manufacturing Capabilities
- Bio4C ProcessPad™ Software Datasheet
- Sf-RVN® Platform For Improving The Safety Profile Of Your Vaccines Process
- Natrix® Q Chromatography Membrane Best Practices Guide
- Integrated Bioprocessing For Biotech Start-ups
- Biotech Start-up Welcome Kit For Bioprocessing
- Switching From Benzonase® Endonuclease Emprove® Expert To Benzonase® Endonuclease Safety Plus Emprove® Expert
- EX-CELL® Advanced HD Perfusion Media
- Flexible Manufacturing Of Vaccines
- BioReliance® Gene Therapy Services
- Benzonase® endonuclease Safety Plus Emprove® Expert Data Sheet
- Benzonase® endonuclease Safety Plus Emprove® Expert Brochure
- Integrated Vector Production Capabilities
- Product Characterization Assay Package - Interlot And Biosimilar Comparability
- Product Characterization Assay Package - Cell Line Development
- Product Characterization Assay Package - Impurities
- Product Characterization Assay Package - Lot Release And Stability Testing
- EX-CELL® Advanced CHO Fed-Batch Medium
- Custom Research-Grade mRNA Manufacturing Services
NEWS
- MilliporeSigma Invests $76 Million To Expand ADC Manufacturing For Novel Cancer Therapies
- MilliporeSigma Expands Its Optimized VirusExpress® Platform For Lentiviral Vectors, Further Enhancing Quality And De-Risking Cell And Gene Therapy Manufacturing
- MilliporeSigma Announces Support Of SaudiVax In Becoming First Developer And Manufacturer Of Halal Vaccines And Biotherapeutics In Saudi Arabia
- MilliporeSigma To Manufacture Next-Generation Biotherapeutics For Alteogen
- MilliporeSigma Announces Organizational Transformation To Strengthen CDMO Offering And Accelerate Future Growth
CONTACT INFORMATION
MilliporeSigma
400 Summit Drive
Burlington, MA 01803
UNITED STATES
Phone: 978-762-5100
